343 related articles for article (PubMed ID: 17963128)
1. Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
Skov MJ; Beck JC; de Kater AW; Shopp GM
Int J Toxicol; 2007; 26(5):411-21. PubMed ID: 17963128
[TBL] [Abstract][Full Text] [Related]
2. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
Wallace MS
Expert Rev Neurother; 2006 Oct; 6(10):1423-8. PubMed ID: 17078783
[TBL] [Abstract][Full Text] [Related]
3. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
Klotz U
Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
[TBL] [Abstract][Full Text] [Related]
4. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
[TBL] [Abstract][Full Text] [Related]
5. Administering ziconotide and monitoring patients treated with ziconotide: expert opinions.
Mitchell AA; Sapienza-Crawford AJ; Hanley KL; Lokey KJ; Wells L; McDowell GC; Stanton-Hicks M
Pain Manag Nurs; 2013 Sep; 14(3):e84-94. PubMed ID: 23972874
[TBL] [Abstract][Full Text] [Related]
6. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
[TBL] [Abstract][Full Text] [Related]
7. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
Wermeling DP
Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
[TBL] [Abstract][Full Text] [Related]
8. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
[TBL] [Abstract][Full Text] [Related]
9. Italian registry on long-term intrathecal ziconotide treatment.
Raffaeli W; Sarti D; Demartini L; Sotgiu A; Bonezzi C;
Pain Physician; 2011; 14(1):15-24. PubMed ID: 21267038
[TBL] [Abstract][Full Text] [Related]
10. Ziconotide: a clinical update and pharmacologic review.
Pope JE; Deer TR
Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340
[TBL] [Abstract][Full Text] [Related]
11. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
[TBL] [Abstract][Full Text] [Related]
12. Ziconotide: an update and review.
Williams JA; Day M; Heavner JE
Expert Opin Pharmacother; 2008 Jun; 9(9):1575-83. PubMed ID: 18518786
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal ziconotide for refractory chronic pain.
Lynch SS; Cheng CM; Yee JL
Ann Pharmacother; 2006; 40(7-8):1293-300. PubMed ID: 16849624
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.
Sanford M
CNS Drugs; 2013 Nov; 27(11):989-1002. PubMed ID: 23999971
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal ziconotide for complex regional pain syndrome: seven case reports.
Kapural L; Lokey K; Leong MS; Fiekowsky S; Stanton-Hicks M; Sapienza-Crawford AJ; Webster LR
Pain Pract; 2009; 9(4):296-303. PubMed ID: 19500276
[TBL] [Abstract][Full Text] [Related]
17. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.
Miljanich GP
Curr Med Chem; 2004 Dec; 11(23):3029-40. PubMed ID: 15578997
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options.
Deer TR; Pope JE; Hanes MC; McDowell GC
Pain Med; 2019 Apr; 20(4):784-798. PubMed ID: 30137539
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature.
Webster LR
Pain Med; 2015 Jul; 16(7):1265-77. PubMed ID: 25645109
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal therapy with ziconotide: clinical experience and considerations on its use.
Vitale V; Battelli D; Gasperoni E; Monachese N
Minerva Anestesiol; 2008 Dec; 74(12):727-33. PubMed ID: 19034250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
